ImmuDyne® Inc.
Investor Relations/News |
The latest news:
ImmuDyne Announces Audited FinancialsFLORENCE, Ky., April 26, 2006 -- ImmuDyne (IMMD), the leading Yeast Beta Glucan Company, today announced fiscal 2005 audited financial results. In the latest fiscal year, ImmuDyne earned slightly more than $0.01 (one cent) per share, had positive net cash provided by operating activities of $342,313, while generating revenues of $2,882,126. The Company auditor, PKF, verified that there were no going concern uncertainties. Moreover, PKF confirmed that ImmuDyne's cash and restricted cash grew to approximately $780,000 at fiscal year end. Management believes that this cash position is more than adequate to meet any of ImmuDyne's obligations for the foreseeable future. ImmuDyne has approximately nineteen million shares outstanding.
About Immudyne® ImmuDyne® shares trade under the ticker symbol IMMD (PK) and the Company can be found on the web at www.immudyne.com Contact: Immudyne®, Inc. Investors: Mark McLaughlin, 1-888-246-6839 simply key in ext. 310